Transmedics Group Inc (TMDX): Next-Year EPS Estimate 75.72%
As of 2026-06-11, Transmedics Group Inc (TMDX) has a next-year EPS growth estimate of 75.72%.
On 2026-06-09, analyst consensus for TMDX's next-year EPS growth shifted from 76.60% to 75.72% — a negative change of 0.88 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at -58.42%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 75.72%
- EPS growth this year
- -58.42%
- EPS next quarter (est)
- $0.56
- Last price
- $73.59
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 75.72% | -58.42% | $0.56 | $73.59 |
| 2026-06-10 | 75.72% | -58.42% | $0.56 | $74.77 |
| 2026-06-09 | 75.72% | -58.42% | $0.56 | $74.29 |
| 2026-06-08 | 76.60% | -58.17% | $0.56 | $71.14 |
| 2026-06-07 | 76.60% | -58.17% | $0.56 | $69.43 |
| 2026-06-04 | 76.02% | -57.96% | $0.55 | $71.37 |
| 2026-06-03 | 76.02% | -57.96% | $0.55 | $69.69 |
| 2026-06-02 | 76.02% | -57.96% | $0.55 | $68.45 |
| 2026-06-01 | 76.02% | -57.96% | $0.55 | $67.53 |
| 2026-05-31 | 76.02% | -57.96% | $0.55 | $67.20 |
| 2026-05-28 | 76.02% | -57.96% | $0.55 | $67.83 |
| 2026-05-27 | 76.02% | -57.96% | $0.55 | $70.15 |
| 2026-05-26 | 76.02% | -57.96% | $0.55 | $70.46 |
| 2026-05-25 | 76.06% | -57.96% | $0.56 | $68.93 |
| 2026-05-24 | 76.06% | -57.96% | $0.56 | $68.93 |
| 2026-05-21 | 76.06% | -57.96% | $0.57 | $68.85 |
| 2026-05-20 | 71.12% | -56.63% | $0.57 | $68.00 |
| 2026-05-19 | 71.12% | -56.63% | $0.57 | $66.13 |
| 2026-05-18 | 71.12% | -56.63% | $0.57 | $68.34 |
| 2026-05-17 | 71.12% | -56.63% | $0.57 | $63.20 |
| 2026-05-14 | 71.12% | -56.63% | $0.57 | $62.04 |
| 2026-05-13 | 71.12% | -56.63% | $0.57 | $63.30 |
| 2026-05-12 | 71.12% | -56.63% | $0.57 | $63.93 |
| 2026-05-11 | 71.12% | -56.63% | $0.57 | $64.30 |
| 2026-05-10 | 71.12% | -56.63% | $0.57 | $67.84 |
| 2026-05-07 | 70.25% | -55.83% | $0.60 | $72.90 |
| 2026-05-06 | 70.25% | -55.83% | $0.60 | $72.92 |
| 2026-05-05 | 51.76% | -49.88% | $0.60 | $94.93 |
| 2026-05-04 | 51.76% | -49.88% | $0.60 | $97.08 |
| 2026-05-03 | 51.74% | -49.87% | $0.60 | $100.01 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Transmedics Group Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Transmedics Group Inc (TMDX) has a next-year EPS growth estimate of 75.72%, based on analyst consensus.
When was the latest EPS estimate revision for TMDX?▾
The most recent revision occurred on 2026-06-09, when analysts adjusted the next-year EPS growth estimate from 76.60% to 75.72%.
What sector and industry does Transmedics Group Inc belong to?▾
Transmedics Group Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TMDX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Transmedics Group Inc (TMDX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports